Ignite Creation Date:
2024-05-06 @ 3:10 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02226757
Status:
UNKNOWN
Last Update Posted:
2014-08-27
First Post:
2014-06-02
Brief Title:
Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients
Sponsor:
Amsterdam UMC location VUmc
Organization:
Amsterdam UMC location VUmc
Organization Data
Organization:
Amsterdam UMC location VUmc
Class:
OTHER
Study ID:
HER2-targeting in EGFR-mutated
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amsterdam UMC location VUmc
Lead Sponsor Class:
OTHER
Responsible Party:
Prof dr EF Smit
Responsible Party Title:
MD PhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Amsterdam UMC location VUmc
Old Name:
None
Old Organization:
None